Clinical Prediction Rule for Stratifying Risk of Pulmonary Multidrug-Resistant Tuberculosis

PLoS ONE - United States
doi 10.1371/journal.pone.0012082
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

Treatment Outcomes of Rifabutin-Containing Regimens for Rifabutin-Sensitive Multidrug-Resistant Pulmonary Tuberculosis

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Impact of Diabetes Mellitus on Treatment Outcome of Multidrug Resistant Pulmonary Tuberculosis

Journal of Evolution of Medical and Dental Sciences
2018English

Different Macrophage Polarization Between Drug-Susceptible and Multidrug-Resistant Pulmonary Tuberculosis

BMC Infectious Diseases
Infectious Diseases
2020English

Risk Factors for Multidrug Resistant Tuberculosis Patients in Amhara National Regional State.

African Health Sciences
Medicine
2015English

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

New England Journal of Medicine
Medicine
2009English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Trends in Multidrug-Resistant Tuberculosis

Journal of Venomous Animals and Toxins Including Tropical Diseases
Animal ScienceZoologyParasitologyInfectious DiseasesToxicology
2008English

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection With Multidrug-Resistant Enterobacteriaceae

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy